No black box warning on record for Losartan Potassium And Hydrochlorothiazide

As of the latest FDA labeling reviewed, Losartan Potassium And Hydrochlorothiazide (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Losartan Potassium And Hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration of losartan potassium and hydrochlorothiazide tablets. ( 5.2 ) Monitor renal function and potassium in susceptible patients. ( 5.3 ) Observe for clinical signs of fluid or electrolyte imbalance. ( 5.5 ) Acute angle-closure glaucoma. ( 5.6 ) Exacerbation of systemic lupus erythematosus. ( 5.7 ) 5.1 Feta

No black box warning on record for Losartan Potassium And Hydrochlorothiazide

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration of losartan potassium and hydrochlorothiazide tablets. ( 5.2 ) Monitor renal function and potassium in susceptible patients. ( 5.3 ) Observe for clinical signs of fluid or electrolyte imbalance. ( 5.5 ) Acute angle-closure glaucoma. ( 5.6 ) Exacerbation of systemic lupus erythematosus. ( 5.7 ) 5.1 Feta

Losartan Potassium And Hydrochlorothiazide Black Box Warning

No black box warning on record for Losartan Potassium And Hydrochlorothiazide

Other warnings & precautions

Losartan Potassium And Hydrochlorothiazide Black Box Warning

No black box warning on record for Losartan Potassium And Hydrochlorothiazide

Other warnings & precautions